Case Study

Flexible IRT Platform Solution For National Lung Cancer Trial

IPad

Cenduit IRT currently provides randomization and trial supply management for the world’s largest precision medicine trial to investigate treatment for non-small cell lung cancer. This trial is investigating genetic biomarker targeted therapy combinations, via partnership between non-profit research organizations and large pharmaceutical companies.

Trial design for this type of study presents unique challenges. These include the need for an IRT platform that can support the rapid incorporation of amendments and account for multiple or potential arms which require different lists of material types and dosages that could be prescribed to patients and supplied to sites. Cenduit’s highly-configurable, flexible technology platform was the solution.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: